{"id":"W2609464715","doi":"10.1186/s13048-017-0319-2","title":"Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells","year":2017,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Dasatinib; Gefitinib; Crizotinib; Ovarian cancer; Medicine; Cancer research; Hepatocyte Growth Factor Receptor; Epidermal growth factor receptor; Internal medicine; Cancer; Oncology; Pharmacology; C-Met; Lung cancer; Tyrosine kinase; Receptor; Chemotherapy; Cisplatin; Hepatocyte growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001522483,0.0002973287,0.0006191352,0.0002493371,0.0001343142,0.0002035399,0.0002309172,0.0001756276,0.00106367],"category_scores_gemma":[0.0001221285,0.00008171491,0.0002858497,0.0002946322,0.000114273,0.0001500071,0.0001654965,0.0003593086,0.0002235399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001954731,"about_ca_system_score_gemma":0.0003404744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004176692,"about_ca_topic_score_gemma":0.001251482,"domain_scores_codex":[0.9998373,0.00003020316,0.00002223756,0.00002641584,0.00004821442,0.00003549762],"domain_scores_gemma":[0.9999558,0.000007432381,0.000007925126,0.000006533383,0.000007909511,0.00001446749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002998853,0.001230924,0.001547435,0.0009079007,0.0001593092,0.0002478804,0.00007469583,0.0008759612,0.9550702,0.0002209678,0.00159386,0.03507195],"study_design_scores_gemma":[0.00148934,0.01582689,0.01603103,0.00002727587,0.0002083163,0.002297489,0.00007957957,0.001463138,0.9400207,0.0001058679,0.02242319,0.00002711598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860187,0.00935374,0.0007284426,0.0002059779,0.0001720954,0.0001540301,0.0006059885,0.00008658636,0.002674502],"genre_scores_gemma":[0.9926438,0.003632392,0.0009314784,0.00007806774,0.0000340597,0.0000971088,0.0008516721,0.000007968205,0.00172346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00106367,"threshold_uncertainty_score":0.003558338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02991683898418688,"score_gpt":0.335500317895296,"score_spread":0.3055834789111091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}